SpringerLink
Log in

Serum melatonin levels and insomnia in patients with Machado-Joseph Disease

  • Original Article
  • Published:
Sleep and Biological Rhythms Aims and scope Submit manuscript

Abstract

We previously reported a patient with Machado-Joseph Disease (MJD) who had severe insomnia and a low serum melatonin (MLT) level, and whose insomnia was alleviated by oral MLT replacement therapy. The aims of this study were to examine whether patients with MJD are likely to have insomnia, and whether there is a relationship between the degree of insomnia and the serum MLT level among patients with MJD. This study included 8 patients with MJD. A 58-year-old-patient with cervical spondylosis was also included in this study to check the condition of the test room for slee**. All patients filled out the Japanese version of Pittsburgh Sleep Quality Index (PSQI-J) questionnaire. We obtained blood samples at 12:00 and 24:00 hours to measure the MLT level. We checked the sleep condition of the patient once an hour and recorded the grade in sleep-logs: the grades of sleep condition were asleep, sleepy, or awake. Statistical analyses were performed to search for correlations between the PSQI score and the serum MLT level or actual sleep time using Spearman’s rank correlation coefficient. Seven of the 8 MJD patients had a total PSQI score of above 5.5 (cut-off level). The daytime MLT level (at 12:00 hours) was below 2.8 pg/mL in all 8 patients, whereas the mean night-time MLT level (at 24:00 hours) of the MJD patients (23.6 ± 17.5 pg/mL) was lower than that of the control patient (43.0 pg/mL) and also lower than the reported cut-off level among healthy people aged 30–50 years (55.5 pg/mL). There was a negative correlation between the total PSQI score and the serum MLT level among the MJD patients (P < 0.05). Our results show that a low serum MLT level may contribute to insomnia in patients with MJD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zhdanova IV, Lynch HJ, Wurtman RJ. Melatonin: A sleep-promoting hormone. Sleep 1997; 20: 899–907.

    CAS  PubMed  Google Scholar 

  2. Dahlitz M, Alvarez B, Vignau J et al. Delayed sleep phase syndrome response to melatonin. Lancet 1991; 337: 1121–4.

    Article  CAS  PubMed  Google Scholar 

  3. Alvarez B, Dahlitz MJ, Parkers JD. The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects. J. Neurol. Neurosurg Psychiatry 1992; 55: 665–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Oren D, Turner E, Wehr TA. Abnormal circadian rhythms of plasma melatonin and body temperature in the delayed sleep phase syndrome. J. Neurol. Neurosurg Psychiatry 1995; 58: 370–85.

    Article  Google Scholar 

  5. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1998; 346: 541–4.

    Article  Google Scholar 

  6. Plamen DP, Phyllis CZ. Melatonin: a clinical prospective. Ann. Neurol. 1997; 42: 545–53.

    Article  Google Scholar 

  7. Takiyama Y, Oyanagi S, Kawashima S et al. A clinical and pathological study of a large Japanese family with Machado-Joseph Disease tightly linked to DNA markers on chromosome 14Q. Neurology 1994; 44: 1302–8.

    Article  CAS  PubMed  Google Scholar 

  8. Takei A, Okawa M, Sasaki H, Hamada T, Tashiro K. Effective melatonin therapy in a case of Machado-Joseph Disease with insomnia. Clin. Neurol. 2000; 40: 736–40. (in Japanese).

    CAS  Google Scholar 

  9. Silveira I, Coutinho P, Maciel P et al. Molecular genetic studies in spinocerebellar ataxias: analysis of SCA1, DRPLA, and MJD mutations in patients from 48 Portuguese ataxia families. Am. J. Medical Genet. (Neuropsychiat Genet) 1998; 81: 134–8.

    Article  CAS  Google Scholar 

  10. Trouillias P, Takayanagi T, Hallett M et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J. Neurol. Sci. 1997; 145: 205–11.

    Article  Google Scholar 

  11. Doi Y, Minowa M, Uchiyama M et al. Psychometric assessment of subjective sleep quality using the Japanese version of Pittsburgh sleep quality index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res. 2000; 97: 165–72.

    Article  CAS  PubMed  Google Scholar 

  12. Busse D, Reynolds C III, Monk T et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28: 193–213.

    Article  Google Scholar 

  13. Vaughan GM. New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. J. Pineal. Res. 1993; 15: 88–103.

    Article  CAS  PubMed  Google Scholar 

  14. Waldhauser F, Weiszenbacher G, Tatzer E et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J. Clin. Endocrinol Metab. 1988; 66: 648–52.

    Article  CAS  PubMed  Google Scholar 

  15. Djeridane Y, Touitou Y. Effects of diazepam and its metabolites on nocturnal melatonin secretion in the rat pineal and Harderian glands. A comparative in vivo and in vitro study. Chronobiol. Int. 2003; 20: 285–97.

    Article  CAS  PubMed  Google Scholar 

  16. Salva MAQ, Guilleminault C. Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia. Neurology 1986; 36: 576–7.

    Article  CAS  PubMed  Google Scholar 

  17. Munschauer FE, Loh L, Bannister R, Newsom-Davis J. Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology 1990; 40: 677–9.

    Article  CAS  PubMed  Google Scholar 

  18. Plazzi G, Corsini R, Provini F et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997; 48: 1094–7.

    Article  CAS  PubMed  Google Scholar 

  19. Schöls L, Haan J, Riess O et al. Sleep disturbance in spinocerebellar ataxias. Is the SCA3 mutation a cause of restless legs syndrome? Neurology 1998; 51: 1603–7.

    Article  PubMed  Google Scholar 

  20. Lou JS, Goldfarb L, McShane L, Gatev P, Hallett M. Use of buspirone for treatment of cerebellar ataxia. An open-label study. Arch. Neurol. 1995; 52: 982–8.

    Article  CAS  PubMed  Google Scholar 

  21. Trouillas P, **e J, Adeleine P et al. Buspirone, a 5-hydroxytryptamine 1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy. Arch. Neurol. 1997; 54: 749–52.

    Article  CAS  PubMed  Google Scholar 

  22. Trouillias P. L-5-Hydroxytryptophan treatment in hereditary and acquired ataxias. Mov. Disord. 1990; 5: 6.

    Google Scholar 

  23. Friedman JH. Machado-Joseph Disease/Spinocerebellar ataxia 3. Responsive to Buspirone. Mov. Disord. 1997; 12: 613–4.

    Article  CAS  PubMed  Google Scholar 

  24. Takei A, Honma S, Kawashima A et al. Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph Disease. Psychiatry Clin. Neurosci. 2002; 56: 181–5.

    Article  PubMed  Google Scholar 

  25. Takei A, Fukazawa T, Hamada T et al. Effects of tandospirone on ‘5-HT1A receptor-associated symptoms’ in patients with Machado-Joseph Disease: An open-label study. Clin. Neuropharm. 2004; 27: 9–13.

    Article  CAS  Google Scholar 

  26. Kish SJ, Schut L, Simmons J et al. Brain acetylcholinesterase activity in markedly reduced dominantly — inherited olivopontocerebellar atrophy. J. Neurol. Neurosurg. Psychiatry 1988; 51: 544–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hokuyukai Neurology Hospital, Niju-yon-ken 2-2-4-30, Nishi-ku, Sapporo, 063-0802, Japan

    Asako Takei, Toshiyuki Fukazawa & Takeshi Hamada

  2. Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan

    Hiroyuki Sohma, Ichiro Yabe & Hidenao Sasaki

  3. Department of Psychiatry, Shiga University of Medical science, Otsu, Shiga, Japan

    Masako Okawa

Authors
  1. Asako Takei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Fukazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takeshi Hamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Sohma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ichiro Yabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hidenao Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masako Okawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Asako Takei.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takei, A., Fukazawa, T., Hamada, T. et al. Serum melatonin levels and insomnia in patients with Machado-Joseph Disease. Sleep Biol. Rhythms 2, 209–214 (2004). https://doi.org/10.1111/j.1479-8425.2004.00144.x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1479-8425.2004.00144.x

Key words

Search

Navigation